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Magnetic separation of peripheral 
nerve‑resident cells underscores 
key molecular features of human 
Schwann cells and fibroblasts: 
an immunochemical 
and transcriptomics approach
Kaiwen Peng1,6,10, David Sant4,7,10, Natalia Andersen2,8,10, Risset Silvera2,5, 
Vladimir Camarena4, Gonzalo Piñero2,9, Regina Graham3, Aisha Khan2,5, Xiao‑Ming Xu1, 
Gaofeng Wang4 & Paula V. Monje 1,2,3*
Nerve‑derived human Schwann cell (SC) cultures are irreplaceable models for basic and translational 
research but their use can be limited due to the risk of fibroblast overgrowth. Fibroblasts are an ill‑
defined population consisting of highly proliferative cells that, contrary to human SCs, do not undergo 
senescence in culture. We initiated this study by performing an exhaustive immunological and 
functional characterization of adult nerve‑derived human SCs and fibroblasts to reveal their properties 
and optimize a protocol of magnetic‑activated cell sorting (MACS) to separate them effectively both as 
viable and biologically competent cells. We next used immunofluorescence microscopy imaging, flow 
cytometry analysis and next generation RNA sequencing (RNA‑seq) to unambiguously characterize 
the post‑MACS cell products. High resolution transcriptome profiling revealed the identity of key 
lineage‑specific transcripts and the clearly distinct neural crest and mesenchymal origin of human 
SCs and fibroblasts, respectively. Our analysis underscored a progenitor‑ or stem cell‑like molecular 
phenotype in SCs and fibroblasts and the heterogeneity of the fibroblast populations. In addition, 
pathway analysis of RNA‑seq data highlighted putative bidirectional networks of fibroblast‑to‑SC 
signaling that predict a complementary, yet seemingly independent contribution of SCs and 
fibroblasts to nerve regeneration. In sum, combining MACS with immunochemical and transcriptomics 
approaches provides an ideal workflow to exhaustively assess the identity, the stage of differentiation 
and functional features of highly purified cells from human peripheral nerve tissues.
Primary cell cultures are commonly jeopardized by the outgrowth of cells that are able to divide at higher rates 
than the desired cell type. Contaminating cells often consist of fibroblasts, the most prevalent cell type in con-
nective tissue, whose primary function is to produce and maintain the structure of the extracellular matrix 
(ECM). Primary Schwann cell (SC) cultures are no exception, as the elaborate connective tissue layers within 
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the epineurium, perineurium and endoneurium contain abundant fibroblasts with potential to proliferate in the 
SC cultures. The risk of fibroblast overpopulation is a major hurdle in establishing and maintaining SC cultures 
from adult human peripheral nervous system (PNS)  tissues1,2, especially in late passage  cultures3 and co-cultures 
with neuronal  cells2. It has been shown that broad-spectrum anti-mitotic drugs, such as cytosine  arabinoside4, 
and agents that elevate intracellular cAMP levels, such as forskolin and cholera toxin, can be used to control 
the number of  fibroblasts5,6 . However, fibroblast elimination in cultures of human origin is rarely achieved. 
Despite the fact that contaminating cells are often referred to as fibroblasts, their origin and special features are 
still uncertain. New research in rodent models have suggested cooperation between SCs and fibroblasts in sup-
porting nerve growth after  injury7,8 but no evidence so far indicates that a similar case occurs in human cells.
Magnetic-activated cell sorting (MACS) provides an advantage to rapidly (i.e., within 2 h) purify rat SCs at 
high efficiency without killing the  fibroblasts9. However, we found that direct translation of purification methods 
from rats to humans was mostly  ineffective10,11 due to species-specific variations in the antigenic properties of 
the cells and other aspects of their growth  control12. Consequently, our primary goal was to perform a pheno-
typic and functional analysis of peripheral nerve-derived human SC cultures to reveal the prevalent cell types 
in the populations and ascertain the most effective strategy for magnetic cell labeling, separation by MACS and 
characterization of the post-MACS cell products. Our next goal was to analyze the purified SC populations and 
establish a comparison to the contaminating cells (herein referred to as fibroblasts generically) to ascertain their 
respective origins and gene expression profiles. We began this study by investigating antibody combinations 
able to discern SCs from fibroblasts and ensure their effective purification. This analysis led to the identifica-
tion of  p75NGFR, the low affinity neurotrophin receptor, as the most reliable and stable cell surface marker to 
distinguish human SCs and fibroblasts via immunofluorescence microscopy and flow cytometry analysis using 
either live or fixed cells. Immuno-tagging with human-specific  p75NGFR antibodies led to the recovery of pure SC 
populations even when the starting preparations contained a predominance of fibroblasts. Ultimately, we used 
next generation whole transcriptome profiling or RNA-seq to unequivocally characterize the MACS-purified 
cells. The RNA-seq profiles of human SCs and fibroblasts revealed their non-overlapping molecular signatures 
underlying their respective neural crest and mesenchymal origins. Strikingly, both SCs and fibroblasts displayed 
gene expression profiles consistent with progenitor cells capable to promote nerve tissue regeneration though 
independent mechanisms involving cell–cell signaling via direct membrane contact, secreted soluble factors, 
and interactions with the ECM.
To conclude, we herein present a convenient and adaptable workflow for the culture, purification and analysis 
of human peripheral nerve-resident cell types (Fig. 1) that was validated using > 10 different cultures. In addition, 
we present an in-depth analysis of purified SCs and fibroblasts of human origin, which have been understudied 
when compared to cells from experimental  animals13. Our workflow can suit the needs of assorted basic and 
translational projects in which understanding human SC function, or using the cells themselves as a cell product, 
has relevance to investigations on peripheral nerve development, therapy, or neurodegenerative disease.
Materials and methods
Cell culture materials, antibodies and hybridoma cell lines. Cell culture grade water, high-glucose 
Dulbecco’s Modified Eagle’s medium (DMEM), Iscove’s Modified Dulbecco’s Medium (IMDM), Hanks Bal-
anced Salt Solution (HBSS, calcium- and magnesium-free), Dulbecco’s Phosphate-Buffered Saline (DPBS), 0.5% 
trypsin–EDTA, 100X Glutamax Supplement, 10,000 U/mL penicillin–streptomycin and 50 mg/mL gentamy-
cin were provided by ThermoFisher (Waltham, MA). Fetal bovine serum (FBS) was provided by HyClone-GE 
Healthcare (Logan, UT). Recombinant heregulin-β1177-244 (herein described as neuregulin) and forskolin were 
furnished by PreproTech (Rocky Hill,NJ) and Sigma-Aldrich (St. Louis, MO), respectively. Poly-L-lysine (PLL) 
and mouse laminin (1 mg/mL) provided by Sigma-Aldrich (St. Louis, MO) were used to coat cell-culture treated 
10-cm dishes, 6- and 24-well plates (Corning). Primary antibodies used for immunostaining were obtained as 
follows: anti-S100β (rabbit polyclonal, Cat # Z0311, DAKO Carpinteria, CA); anti-fibronectin (mouse mono-
clonal, Cat # sc-8422, Santa Cruz); anti-smooth muscle actin or SMA (Cat # MS113-PO, ThermoFisher); anti-
vimentin (rabbit monoclonal, Cat # D21H3, Cell Signaling, Danvers, MA); anti-CD44 (mouse monoclonal, Cat 
# 156-3C11, Cell Signaling), anti-Sox10 (rabbit monoclonal, Cat # ab155279, Abcam), and anti-nestin (Cat # 
ab6142, Abcam). Fluorescent antibodies used for flow cytometry were the following: APC-conjugated anti-
human CD271/p75NGFR (Clone ME20.4, Cat # 345108), and FITC-conjugated anti-human CD90/Thy-1 (Clone 
5E10, Cat # 328108) both from Biolegend (San Diego, CA). The hybridoma cell lines clones HB-8737 (primate/
human-specific, monoclonal anti-p75NGFR) and HFN36.3 (human-specific fibronectin) were acquired from the 
American Type Culture Collection (ATCC, Manassas, VA). O4 hybridoma cells were a gift of Dr. Mellita Schach-
ner to Dr. Patrick Wood. Alexa Fluor 488, 546 and 647-conjugated antibodies in the form of goat anti-rabbit 
IgG (Cat # A-11035), goat anti-mouse IgG (Cat # A-11001) and goat anti-mouse IgM (Cat # A21042) were sup-
plied by ThermoFisher. The IgG magnetic microbeads (Cat # 130-048-401) and the Anti-Fibroblast MicroBeads 
Miltenyi (Cat #130-050-601) were provided by Miltenyi Biotec GmbH (Bergisch Gladbach, Germany).
Preparation of PLL‑ and laminin‑coated surfaces. Plates were sequentially coated with PLL and 
mouse laminin to allow for a strong adhesion of the human SCs. A 100X PLL stock solution (2%) was prepared 
by dissolving the PLL powder in borax/boric acid buffer (1.9% sodium tetraborate and 1.2% boric acid), followed 
by sterile filtering. From this, a working solution of PLL was prepared in cell culture grade water and used as 
coating solution to completely cover the surface at a ratio of 1 mL per 25  cm2. After a 1-h incubation at room 
temperature (RT), the PLL-coated substrate was rinsed with cell culture grade water and allowed to dry com-
pletely prior to use or storage at 4 °C. The dishes were subsequently coated for at least 1 h with a laminin solution 
prepared in chilled DPBS at a ratio of 0.7–1 µg of laminin per  cm2 of coated surface. The laminin solution was 
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Figure 1.  An optimized workflow to efficiently purify and characterize SCs and fibroblasts from adult human 
peripheral nerve tissue. This protocol uses heterogeneous human cultures containing cells identifiable as SCs 
and fibroblasts as evidenced by expression of  p75NGFR, a SC (neural crest)-specific receptor. MACS of p75-
labelled cells allowed the fast recovery of SCs and fibroblasts retaining their viability and biological activity. The 
rounds of MACS required to achieve > 95% SC purity was dependent on the degree of fibroblast growth (high or 
low, as indicated). Immunofluorescence microscopy, flow cytometry and transcriptome (RNA-seq) analysis were 
used to confirm the identity and purity of the MACS-purified cells. Some key lineage- and stage-specific genes 
revealed by RNAseq (bottom panel) emphasized the independent origin of human SCs and fibroblasts, their 
relative immaturity, and the heterogeneity of the fibroblast populations. The genes highlighted in color were 
confirmed by immunological methods.
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removed immediately before seeding the cells with the precaution of not letting the laminin substrate dry at any 
time. Of note, the adhesion of human SCs to freshly coated laminin plates was not changed when provided in 
the range of concentration specified above. Laminin was used in the lower range for routine subculture and re-
plating in multiwell dishes but a ~ 30% excess of laminin was preferred for cell plating after MACS to enhance 
the survival of cells subjected to stress conditions. Cells were seeded in 10-cm dishes for routine expansion and 
MACS separation, 24-well plates for fluorescence microscopy, and 6-well plates for flow cytometry and RNA-seq 
analysis.
Culture and expansion of primary human SCs from cryopreserved stocks. Primary human SC 
cultures were prepared and expanded as described in our previous  studies14,15 by using methods analogous to 
those used in clinical  trials10. The cultures were obtained from postmortem human peripheral nerves made 
available as deidentified (coded) biospecimens by the National Disease Research Interchange (NDRI) and the 
Life Alliance Organ Recovery Agency (LAORA) of the University of Miami Miller School of Medicine to the lab-
oratories of Paula Monje and Patrick Wood at The Miami Project to Cure Paralysis, respectively, as described in 
our previous  studies15,16. NDRI and LAORA strictly adhere to government regulations and guidelines regarding 
donor authorization and confidentiality, and ensure that informed consent is obtained from the donors (or the 
next-of-kin thereof) for research use. In vitro experimentation with human tissues and cells in this project was 
approved and deemed to constitute non-human subjects research by the Human Subjects Research Offices of the 
University of Miami and Indiana University. Procedures were further reviewed and approved by the Institutional 
Biosafety Committee of Indiana University. All experiments were done using banked cell cultures obtained from 
non-pathological nerve tissues from males and females, ages 10 to 66, that tested negative for blood borne 
viruses. Cryopreservation of cell stocks was done in medium consisting of dimethyl sulfoxide (DMSO) and FBS 
at a ratio of 1:9. Human SCs from the nerve roots comprising the cauda equine were used in experimentation 
unless otherwise noted. Experiments used early passage SC cultures usually collected after one to three rounds 
of subculture albeit some exceptions, as indicated in the figure legends. The cultures were selected according to 
their initial content of fibroblasts irrespective of the passage number or donor-specific characteristics such as 
gender and age.
Cryovials of human SCs were quickly thawed at 37 °C and re-suspended in 10–15 mL of DMEM contain-
ing 10% FBS (heat-inactivated in house) prior to collection by centrifugation and plating directly onto PLL-/
laminin-coated 10-cm dishes at a density of 1–2 × 106 cells /dish. Cells were quantified and tested for viability 
using the Trypan blue exclusion assay. Cells were cultured in mitogens-supplemented growth media consisting 
of high-glucose DMEM, 10% FBS, 1% GlutaMAX, 1% penicillin–streptomycin, 10 nM neuregulin and 2 µM 
forskolin. This media formulation is referred here as ‘SC growth media or mitogens’ in the text and figures. The 
cells were maintained in a 37 °C incubator set to 8–9%  CO2 for optimal growth. The cultures were observed 
under a phase contrast microscope to confirm cell adhesion to the substrate within 2–3 h of seeding. Regular 
media changes were performed until the cells reached confluency. For passaging, the cells were dislodged from 
their dishes to obtain a single cell suspension via enzymatic treatment with trypsin/EDTA prepared in calcium- 
and magnesium-free HBSS. The enzymatic dissociation was monitored by phase contrast microscopy to ensure 
that a single cell suspension was obtained without overexposing the cells to trypsin. The trypsinization step was 
interrupted by addition of DMEM containing 10% FBS followed by low speed centrifugation. Cells to be used 
in MACS were plated in SC growth media at an initial density of  106 cells per 10-cm dish and cultured until 
confluency. Experiments that used unpurified SC cultures were carried out in mitogens-supplemented medium.
Fibroblast cultures obtained via differential adhesion to plastic dishes. Prior to establishing 
MACS protocols, a simple method of differential adhesion was implemented to obtain purified fibroblast cul-
tures for routine experimentation. For this, a single cell suspension of human SC cultures containing fibroblasts 
was plated onto non-coated 10-cm cell culture dishes and incubated at RT for 15 min to allow the adhesion of 
fibroblasts but not SCs. The cultures were washed with L15 medium to remove floating cells and the remaining 
cells (adherent) were expanded in DMEM containing 10% FBS without added mitogens (in uncoated dishes) up 
until confluency. These cultures were passaged twice in FBS-only medium and banked by  cryopreservation17. 
Cells obtained by this method exhibited an S100β negative,  p75NGFR negative, fibronectin positive phenotype. 
This protocol was useful to reduce the number of fibroblasts in SC cultures that already had a low proportion of 
contaminating cells (< 20%) but was ineffective to purify massively contaminated cultures.
Culture of hybridoma cell lines and preparation of conditioned medium. Monoclonal antibodies 
against  p75NGFR, O4 and fibronectin were produced in house, stored in aliquots at − 80 °C and used in the form of 
undiluted hybridoma culture supernatant in all cell labeling experiments. The hybridoma cells were plated and 
expanded as suspension cultures in medium consisting of IMDM supplemented with 10% FBS, 1% GlutaMAX, 
1% penicillin/streptomycin and 0.1% gentamycin. These cells were sub-cultured at a 1:4 ratio in T75 flasks. The 
culture supernatant was collected by low speed centrifugation after each round of expansion. The time of collec-
tion was determined when it was visually appreciated that the medium turned yellow in  color11. Every batch of 
hybridoma culture supernatant (herein referred to as ‘conditioned medium’) was tested for its labeling activity 
and specificity using positive control cells. Adherent human SCs and fibroblasts were used to validate the quality 
of  p75NGFR, O4 and fibronectin antibodies.
Live cell immuno‑labeling and MACS. For MACS, human SCs were expanded up until at least  107 cells 
were available per donor or batch. Aliquots containing up to 2 × 107 cells were incubated with 5 mL of undiluted 
 p75NGFR conditioned media for 20 min at 4 °C, with agitation every 5 min to maintain the cells in suspension. 
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The cells were collected by low speed centrifugation, washed with DMEM containing 10% FBS and ultimately 
resuspended in 80 µL of sorting buffer (0.5% BSA, 2 mM EDTA prepared in D-PBS, pH 7.2) containing 20 µL 
of anti-IgG antibodies conjugated to magnetic microbeads. Incubation was carried out for 20 min at 4 °C before 
addition of 5 mL of DMEM containing 10% FBS. Removal of unbound antibodies was carried out by low speed 
centrifugation. The labeled cells were resuspended in BSA sorting buffer without EDTA prior to applying them 
to the column/s, following the manufacturer’s instructions (Miltenyi Biotech). Three washes of the column with 
BSA sorting buffer were performed to elute the cells that did not express  p75NGFR (eluted fraction). Subsequently, 
the columns were detached and the  p75NGFR positive cells (retained fraction) were released in 1 mL of sorting 
buffer after applying positive pressure with a plunger as suggested by the manufacturer. Both the eluted and 
retained cells were immediately pelleted, re-suspended in DMEM containing 10% FBS, counted and tested for 
viability. A representative sample of unpurified cells (herein referred to as the ‘total fraction’) was allocated 
separately from the onset and used as control for quantitative analysis by immunofluorescence microscopy and 
flow cytometry. The SC-enriched fractions were plated in mitogens medium whereas the fibroblast-enriched 
fractions were plated in FBS-only supplemented medium to maximize the health and proliferation of each popu-
lation right after MACS. Importantly, the expression of the markers used for cell type identification via immu-
nostaining were visually unchanged when the fibroblasts were placed in FBS-only medium.
Both MS or Large-Cell columns (Miltenyi) were tested with good results. While both column types rendered 
purities > 95% SCs, separation by means of Large-Cell columns allowed for a superior yield (i.e. the cells recov-
ered in the eluted and retained fractions combined with respect to the total number of cells passed through the 
column) despite a proportion of SCs eluted together with the fibroblasts. MS columns were preferred to obtain 
high purities in both the eluted and retained fractions despite the lower speed of separation and consequent 
loss in total cell yields. Scalability to larger cell numbers (i.e. > 2 × 107 cells) was rarely needed but was possible 
by adjusting the volumes of primary and secondary antibodies, and using additional columns as dictated by the 
number of cells. Technical adjustments to this protocol for an increased speed of separation, enhanced purity 
and/or yields can be found in our recent  publication11.
Determination of cell counts, viability and proliferation. Cells in suspension were stained with a 
0.2% solution of Trypan blue and subjected to quantification and vitality assessment using a BioRad TC20 auto-
mated cell counter. DNA synthesis was determined by utilizing the Click-iT Plus EdU Alexa Fluor 594 Prolifera-
tion Assay Kit (Thermo-Fisher) that uses EdU (5-ethynyl-2′-deoxyuridine) added to the culture medium to label 
the DNA of actively dividing cells. A reaction with a fluorescent azide allows the visualization of EdU-labelled 
DNA in dividing nuclei by fluorescence microscopy. The EdU labeling reagent was added to the culture medium 
of adherent cells at a final concentration of 1–2 µM. It was added 18–24 h after seeding the cells and maintained 
in the culture medium up until fixation with 4% paraformaldehyde in PBS. The EdU reaction was performed 
according to the manufacturer’s instructions 48  h after plating. The cells were counterstained with Hoechst 
33342 prior to fluorescence microscopy imaging.
[3H]-thymidine incorporation assays used sub-confluent cultures of human nerve-resident fibroblasts 
obtained via selective adhesion to  plastic14. The fibroblasts were plated on PLL-laminin-coated 24-well dishes 
(50,000 cells/well) and incubated for 1 d in HEPES-buffered DMEM containing 1% FBS to lower the prolifera-
tion rate prior to addition of  [3H]-thymidine (0.25 µCi/ml) under the conditions described in the figure legends. 
Incorporated tritium into the cells was determined by liquid scintillation counting typically 72 h post-stimulation. 
Neuregulin (10 nM), forskolin (2 µM), and FBS (10%) were used alone and in combination to gauge the respon-
siveness of fibroblasts to the chemical factors used routinely in the formulation of human SC growth  media16. 
Other factors used as potential mitogens were the following: db-cAMP (100 µM), PDGF-BB (20 ng/mL), IGF-1 
(50 ng/mL), FGF-2 (20 ng/mL), EGF1 (20 ng/ml), and TGFβ (20 ng/mL).
Identification of senescent cells. A cytochemical assay that uses the chromogenic compound X-gal 
(5-bromo-4-chloro-3-indoyl β-D-galactopyranoside) as substrate for the pH-dependent β-galactosidase 
(SA-βGAL) was used to determine senescence in fixed cells, according to the manufacturer’s instructions (Cell 
Signaling). The cleavage of X-Gal by β-galactosidase at pH 6 renders an insoluble intracellular blue precipitate 
that allows the visual discrimination of senescent cells. The percentage of stained cells, as seen by bright field 
microscopy, was determined with respect to the total number of cells, as revealed by fluorescent nuclear stain-
ing using DAPI. In some experiments, cells were immunostained with anti-p75NGFR antibodies to discriminate 
human SCs from fibroblasts.
Immunofluorescence microscopy. Following cell sorting, replicates of the total, eluted and retained 
fractions were seeded on PLL-/laminin-coated multi-well dishes to assess cell purity via immunofluorescence 
microscopy imaging. The MACS-purified cells were allowed to adhere and proliferate for 48 h in SC growth 
medium. The cells were sequentially fixed with 4% paraformaldehyde and cold methanol (− 20 °C) to allow co-
staining with antibodies targeting membrane (e.g.  p75NGFR, and CD44) and intracellular antigens (e.g. S100β, 
vimentin, SMA, Sox10, and nestin). Cells were blocked with 5% normal goat serum in PBS prior to addition 
of the antibody combinations described in the figure legends. After overnight incubation at 4 °C, the cells were 
washed with PBS and incubated with fluorescent secondary antibodies (1:300) prepared in 5% normal goal 
serum containing DAPI. Incubation with secondary antibodies was carried out for 1 h at RT, shielded from light. 
Following staining, the cells were post-fixed, mounted and observed under an Olympus 1X70 inverted fluores-
cence microscope. Cells were assessed for the positive or negative expression of  p75NGFR, S100β and other mark-
ers in reference to total nuclear staining (DAPI). Large surface areas were scanned via High Content Screening 
Automated Fluorescent Microscopy (Thermo Scientific Cellomics Arrayscan Vti High Content System Reader, 
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Version 6.6.2.0.). Images of the green (488 nm), red (546 nm) and UV (DAPI) fluorescence shown in the figures 
were taken from the central area of each well. At least 36 microscopic fields taken at 10× were used for quanti-
fication.
Flow cytometry analysis. Viable cells in suspension were analyzed for the expression of SC- and fibro-
blast-associated markers by flow cytometry. Each sample consisted of  106 cells comprising the total (unpurified), 
eluted and retained fractions. Cells were washed with flow cytometry buffer consisting of 1% BSA and 0.1% 
sodium azide prepared in PBS prior to aliquoting them into equal samples for live cell labeling using fluores-
cent antibodies against extracellular antigens specifically expressed in human SCs (APC-CD271) and fibroblasts 
(FITC-CD90), respectively. Cells were labeled with 5 µL of each fluorescent antibody per million cells in 100 µL 
flow cytometry buffer, as recommended by the manufacturer. Incubation was carried out for 0.5–1 h at RT pro-
tected from light. Stained cells were washed twice with flow cytometry buffer, fixed with 4% paraformaldehyde 
prepared in PBS for 15 min, washed again with flow cytometry buffer, and pelleted by centrifugation. The cells 
were resuspended in 300 µL of flow cytometry buffer and analyzed within 24 h of staining. At least  104 events per 
condition were acquired using a Becton–Dickinson CytoFLEX flow cytometer (San Jose, CA, USA). Compen-
sation controls were prepared with both unstained and single-stained samples. Quantification was performed 
using FlowJo v10.0.8 software (FlowJo, Ashland, OR, USA) after excluding doublets and dead cells.
RNA isolation, sequencing by RNA‑seq and bioinformatics analysis. For RNAseq, we used MACS-
purified human SCs and fibroblasts derived from a typical passage-1 culture from a 51 year-old donor. The SCs 
and fibroblasts were plated for 2 days in mitogens and FBS-only supplemented media, respectively, before collec-
tion as a single cell suspension. The cells were allowed to recover after MACS but they were not subjected to sub-
culture. A total of 2 × 106 cells from the retained and eluted fractions were collected by trypsinization, pelleted by 
centrifugation and stored at − 80 °C for RNA isolation. RNA extraction and DNAase treatment was conducted 
using the RNeasy Mini Kit (Qiagen, Valencia, CA) following the manufacturer’s instructions. The quality of the 
RNA was deemed suitable for sequencing on the basis of RNA integrity numbers above 9 as per the BioAnalyzer 
2000 (Agilent, Santa Clara, CA). A total of 560 ng of RNA was used for sequencing. RNA-seq was carried out 
at the Sequencing Core of the John P. Hussman Institute of Human Genomics (University of Miami) using the 
TruSeq Stranded Total RNA Library Prep Kit (Illumina, San Diego, CA). Briefly, after ribosomal RNA (rRNA) 
was depleted, sequencing libraries were ligated with standard Illumina adaptors and subsequently sequenced on 
a Hiseq2000 sequencing system (125 bp paired-end reads, 4 samples per lane; Illumina, San Diego, CA, USA).
Raw sequencing reads were aligned to the reference genome (Homo sapiens) and quantified using STAR 
software. Statistically significant differential expression for each gene was assessed using two software packages: 
edgeR and DESeq2, as described  recently14. Density plots were generated and a limit of sensitivity was found 
to be 2.5 read counts per million (RCPM)18. To reduce false positives, only transcripts above 2.5 RCPM in at 
least one cell type and an adjusted P-value (false discovery rate, FDR) of 0.05 by both DESeq2 and edgeR were 
considered differential between sample types. Differential transcripts were visualized in the form of a volcano 
plot using scatterplots in R (https ://www.R-proje ct.org). The genes present only in SCs were determined by 
selecting the transcripts exhibiting a minimum of tenfold greater expression in SCs than in fibroblasts if the 
read count in fibroblasts was negligible (< 1 RCPM). If the RCPM in fibroblasts was not negligible (> 1 RCPM), 
a minimum of 50-fold change in expression was used as the cutoff for genes expressed only in SCs to account 
for up to 2% contaminating fibroblasts in the SC cultures. A similar method was used to determine the genes 
expressed only in fibroblasts. Pathway analysis was conducted on lists of genes expressed only in one cell type 
using  enrichR19. Information from the following databases was used to construct all presented bar graphs and 
Venn diagrams: Jensen Tissues, Reactome and Gene Ontologies (GO) Biological Processes. Gene Set Enrichment 
Analysis (GSEA) was used to confirm positive results of pathway analysis and generate enrichment  plots20,21. 
Additional technical and scientific information was obtained from GeneCards (https ://www.genec ards.org/). 
Annotated names were used for the identification of gene transcripts in the figures. Only the most relevant iso-
forms/variants in each gene group were selected for presentation. Selection was based on their relative levels of 
expression (RCPMs or fold induction) as well as their known relevance to the function of the cell types analyzed.
Statistical analysis. Statistical analysis by means of the Student’s t-Test or One-Way ANOVA was per-
formed using Sigma Plot 12.0 (Systat Software, San Jose, CA). For multiple comparisons, Bonferroni correction 
was used. Experimental data was expressed as the mean ± standard deviation (SD) of triplicate samples from 
each experimental condition. Values of significant correlations were indicated in the table and figures according 
to their degree of significance (* p < 0.05, * * p < 0.01 and *** p < 0.001). Statistical significance was accepted for 
p < 0.05.
Results
Peripheral nerve‑derived human fibroblasts are non‑senescent proliferative cells. SC cultures 
are usually heterogeneous and contain non-glial cells in different proportions. Fibroblasts are a major component 
of the contaminating populations (Fig. 2a) but other cell types such as immune cells, stem cells and pericytes 
can also prevail in cultures of human origin. The non-glial cells can effectively adhere to uncoated, plastic dishes 
and this differential attribute can be exploited to reduce the impact of fibroblast contamination in SC  cultures22. 
Fibroblasts are rapidly proliferating cells that respond to a broad range of growth factors (Fig. 2b–c). This stays 
in stark contrast to SCs, which are highly selective for, and also strictly dependent on, the addition of neuregulin 
and cAMP-inducing agents for a maximal rate of  growth5,14,15. The fibroblasts express ErbB2 but as opposed to 
the human SCs, they do not express the ligand binding partner of the ErbB co-receptor,  ErbB323,24 (Fig. 5b), and 
7
Vol.:(0123456789)
Scientific Reports |        (2020) 10:18433  | https://doi.org/10.1038/s41598-020-74128-3
www.nature.com/scientificreports/
fail to proliferate when stimulated with neuregulin (Fig. 2c). Yet, the fibroblasts respond to PDGFBB, FGF-2 
and undefined factors present in serum with an increase in cell division (Fig. 2c). Forskolin and other inducers 
of cAMP (e.g., the membrane permeable analog db-cAMP) moderately reduce the serum (FBS)- and growth 
factor (PDGFBB and FGF-2)-induced proliferation of fibroblasts (Fig. 2c, and data not shown). This response 
contrasts sharply with the cAMP-driven synergistic enhancement of neuregulin-induced proliferation typical of 
human  SCs5,15,16.
Nevertheless, the addition of cAMP-stimulating agents was only partially effective in preventing fibroblast 
proliferation, as they continue to divide well even in forskolin-supplemented medium (Fig. 2b–c). Indeed, the 
simple removal of mitogenic factors (neuregulin/forskolin) can be sufficient to allow them to expand rapidly and 
Figure 2.  Characterization of adult peripheral nerve-derived human SCs and fibroblasts. (a) Discrimination 
of SCs and fibroblasts via double immunolabeling with S100β and fibronectin antibodies showing strong 
cytoplasmic expression of S100β in the SCs and extracellular location of fibronectin in the fibroblasts. Images 
taken at low (upper panels) and high magnification (lower panels) are provided to illustrate the impact of 
fibroblast overgrowth in a typical human SC culture (passage-2, 18 year old, male) deprived of mitogenic factors 
for 10 days. SCs in confluent cultures have a tendency to display an elongated, spindle-shaped phenotype. 
Although morphological differences can aid in SC versus fibroblast identification, immunostaining is needed 
for clear discrimination, especially in those areas where the SCs intermingle with the fibroblasts (a, lower 
right panel). (b) Fibroblast proliferation in human SC cultures. SC cultures were maintained in SC growth 
medium (standard conditions) and allowed to incorporate EdU for 3 days before fixation and detection of EdU 
in the nucleus (red) of SCs (red arrowheads) and fibroblasts (white arrowheads), as determined by  p75NGFR 
immunostaining (green). Quantitative data from 3 independent early passage SC cultures is shown to illustrate 
the variability in the extent of fibroblast proliferation under optimal conditions for SC growth. Donors were 
identified as D1 (18 year old, male), D2 (10 year old, female) and D3 (51 year old, male). (c) Mitogenic effect of 
purified growth factors and serum in human fibroblasts obtained by differential adhesion to plastic. Fibroblasts 
were plated in multiwell dishes to assess the incorporation of  [3H]-thymidine in the absence (control) and 
presence of the indicated mitogenic factors (see Methods). Statistical significance was obtained from a One-
Way ANOVA. Experimental treatments showing non-significant differences (ns) with respect to the control 
(no growth factors added, left bars) are indicated. (d) Lack of senescence in contaminating human fibroblasts. 
Late passage cultures (passage-4) enriched in senescent human SCs were used to determine SA-βGAL activity 
(shown in red as artificial color). Two areas (insets) were selected to depict the distribution of SA-βGAL activity 
(red) in  p75NGFR positive cells (green). Quantitative data and level of significance (T-test) from 2 independent 
cultures (D1, 18 year old, male, and D2, 51 year old, male) are shown on the right panel. DAPI or Hoechst (blue) 
was used to label cell nuclei in these and all subsequent fluorescence microscopy images.
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overtake the cultures. The magnitude of fibroblast overgrowth is exemplified in Fig. 2a, which shows a panoramic 
view of an initially > 90% pure human SC culture that was maintained in FBS-supplemented, neuregulin- and 
forskolin-free medium for 10 days. In these cultures, the fibroblasts developed within densely populated clusters 
that segregate from the SC bundles. The distinct pattern of growth was revealed by co-immunostaining with 
antibodies against fibronectin, a major component of the nerve’s ECM, and S100β, a calcium-binding protein 
widely used as SC marker in human peripheral nerve  cultures25.
Human nerve-resident fibroblasts can divide at similar or even higher rates than the human SCs in SC growth 
medium though variability is observed according to the donor (Fig. 2b) and possibly other variables. Strikingly, 
most non-glial cells failed to undergo senescence under conditions that allowed human SCs to become incom-
petent to proliferate likely due to senescence, as evidenced by SA-βGal activity assays (Fig. 2d). This is one main 
reason why, if not eliminated in due time, the fibroblasts can overwhelm the human SC cultures in a few rounds 
of subculture.
In closing, the human fibroblasts exhibit a competitive advantage over the SCs under conditions supportive 
of SC expansion. These non-glial cells do not require special substrates or purified mitogenic factors, and, as 
noted here for the first time, they are highly resistant to undergo senescence.
Cell type selective immunolabeling is required to faithfully identify human SCs and fibro‑
blasts. Achieving a thorough understanding of the population used as a starting material is the first step 
needed to design a successful purification strategy. Generally, SCs are spindle-shaped, elongated cells much 
smaller in size when compared to fibroblasts, which can be found within clusters of tightly packed cells or 
intermingling with individual human SCs depending on the experimental setting (Fig.  2a). The appearance 
of the nuclei can also help discriminate glial from non-glial cells as the nuclei of SCs is roughly oval and more 
condensed than the one of fibroblasts (Fig. 2a). Yet, cellular morphology can be affected by a variety of factors, 
including the type of substrate, the confluency of the cultures, and the culture medium. As shown in Fig. 3a and 
Supplementary Fig. 1, human SCs can adopt a transient flattened, expanded phenotype that resembles the one of 
fibroblasts and cannot be discriminated clearly unless immunological methods are used.
Thus, we set out to test the reactivity and specificity of a variety of commercially available antibodies with 
potential to discern SCs from fibroblasts in mixed human nerve-derived cultures. This was needed because most 
antibodies commonly used to identify rodent (rat) SCs do not cross-react with the respective human antigens 
or give the same level of specificity. As presented in Fig. 3a, we found a few antibody combinations with capacity 
to detect cell type-related proteins strongly and specifically in fixed cells. As expected, immunostaining with 
antibodies against S100β could clearly discern SCs and fibroblasts (Fig. 2a). Alternative antibody combinations 
involved the detection of the following widely known SC-specific proteins: (1)  p75NGFR, which is an integral 
membrane receptor expressed at high levels in SCs and other cells derived from the neural crest (Figs. 2b,3a), 
(2) nestin, which is a cytoplasmic intermediate filament related to neurofilament expressed in mitotically active 
nerve cells (Fig. 3a), and (3) Sox10, which is a nuclear transcription factor with a well-assigned role in neural 
crest development and SC myelination (Fig. 3a). The transcription factors Sox2 and Oct6 exhibited SC-specific 
nuclear localization, as shown  previously26, but their uneven levels of expression within the S100β positive popu-
lation limited their use to discriminate SCs from fibroblasts effectively (not shown). Consistent with a previous 
 report27, the intermediate filament vimentin and the anchoring membrane receptor CD44 were evenly expressed 
in human SCs and fibroblasts (Fig. 3a).
Essentially all S100β positive cells co-expressed CD44 and  p75NGFR as determined by image analysis (Sup-
plementary Fig. 1) though some populations displayed nuclear rather than cytoplasmic S100β localization (not 
shown), as observed  previously26. For practical purposes, and considering the fact that normal nerve tissues were 
used to derive our cultures, we have regarded S100β and  p75NGFR equally suitable for human SC identification 
regardless of the cellular localization of the antigenic signal. However, caution should be taken in interpreting 
S100β immunostaining results in other types of cultures such as those suspected of CNS glia contamination 
because S100β positive cells that are not SCs are likely to  emerge13,28.
Unfortunately, we were unable to find a common marker for nerve-resident fibroblasts. Fibronectin was 
strongly expressed in fibroblasts, but it was also expressed in SCs at the protein (Fig. 2a) and mRNA levels 
(Fig. 5d). Fibronectin immunostaining is evidenced as a diffuse fibrous network around the cells and this pre-
cludes a clear delimitation of positive and negative cells by image analysis (Fig. 2a). In general, we found that 
detection of ECM proteins such as fibronectin (Fig. 2a), laminin (not shown), and collagen type IV (Fig. 3a) was 
more reliable when done in conjunction with markers such as S100β and  p75NGFR. High levels of smooth muscle 
actin or SMA, a marker typical of myofibroblasts and pericytes, was found in some contaminating cells (Fig. 3a) 
as reported  previously29. However, the proportion of SMA positive cells differed in independent cultures and 
the levels of SMA protein changed drastically with high doses of cAMP (not shown).
Overall, these results indicate the need for cell type-specific immunolabeling in order to unequivocally discern 
SCs and non-glial cells. This is important considering the morphological variability and the antigenic heteroge-
neity that lies within SCs and fibroblasts of human  origin13,14.
Cell surface  p75NGFR immunolabeling is suitable for the quantification and MACS‑assisted puri‑
fication of human SC cultures. Magnetic labeling and separation via MACS require cell type-selective 
antibodies able to bind to an epitope on the surface of living cells. In addition, the antigen should be stably 
expressed in the target cells and preserved after trypsinization to allow the labeling of cells in suspension. Two 
candidate SC-specific membrane antigens were investigated for their potential use in the MACS of human 
peripheral nerve cells. One of these antigens was  p75NGFR and the other was the myelin-specific galactosphin-
golipid known as O4, which is expressed on the plasma membrane of central and peripheral myelinating glial 
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 cells30. Antibodies against  p75NGFR and O4 are suitable for the MACS of rodent  SCs31,32. Though cultured human 
SCs can express O4, the levels are cAMP-dependent and variable within individual  cells33, as denoted by the 
rapid disappearance of the O4 signal in cells shifted to forskolin-free medium (Fig. 3b). Indeed, the percentage 
of O4 positive human SCs rarely surpasses 20% in mitogens medium (Fig. 3b) or SC differentiation  medium14. 
Figure 3.  Immunological characterization of mixed populations of human SCs and fibroblasts. (a) Useful 
antibody combinations for co-immunostaining of fixed cells identifying SCs (left), fibroblasts (right) and both 
cell types (middle panels). Arrowheads in all panels point to selected fibroblasts characterized by the lack of 
 p75NGFR, Sox10, S100β and nestin. High levels of vimentin (intracellular, red) and CD44 (membrane, green) 
were present in SCs and fibroblasts. Most fibroblast cultures contained SMA positive (arrowheads) and negative 
(arrows) cells. (b–c) Cell surface immuno-labeling of live human SCs. (b) Comparison between O4 and  p75NGFR 
immuno-detection in adherent cells. Sub-confluent cultures of human SCs were incubated for 3 days in SC 
growth medium (+ mitogens) or in DMEM containing 1% FBS (- mitogens) prior to live cell labeling with O4 
and  p75NGFR antibodies (green). Immunostaining with S100β antibodies (red) and DAPI (blue) was carried out 
after fixation.  p75NGFR levels were high and homogeneous both in the absence and in the presence of mitogenic 
factors (b, lower panels). By contrast, O4 levels were variable and mitogen-dependent (b, upper panels). Some 
S100β positive SCs did not express O4 (b, white arrows) despite prolonged incubation in SC growth medium. (c) 
Fluorescence microscopy imaging (upper panels) and flow cytometry analysis (lower panels) of human cultures 
affected by various degrees of fibroblast contamination (indicated as high and low in the upper panels).  p75NGFR 
antibodies were used to stain adherent cells (fluorescence microscopy) and cells in suspension (flow cytometry). 
Thy-1 antibodies (CD90) were used only for flow cytometry analysis due to empirical data showing ineffective 
detection in adherent (live or fixed) cells. These images attest to the high specificity of S100β (cytoplasmic) and 
 p75NGFR (membrane) co-immunodetection in SCs but not fibroblasts. Whereas Thy-1 (CD90) expression was 
absent in SCs (c), the levels of Thy-1 were heterogeneous in  p75NGFR negative cells.
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By contrast,  p75NGFR expression was high and homogenous across all human SC cultures selected for study (Sup-
plementary Fig. 1) irrespective of mitogens and serum (Fig. 3b).  p75NGFR antibodies were suitable for live cell 
labeling under conditions of adherence and suspension, which enabled the quantification of  p75NGFR positive 
cells by fluorescence microscopy imaging and flow cytometry analysis (Fig. 3c). Though MACS of O4 positive 
human SCs was feasible in certain populations (not shown), the separation of  p75NGFR -expressing cells was pre-
ferred due to the broad expression of  p75NGFR in SCs and its invariance with respect to culture variables, passage 
number and donor-specific characteristics. Monoclonal antibodies from the hybridoma cell line HB8737 (anti-
p75NGFR, human-specific) were efficacious to both immuno-stain and magnetically sort SCs in all populations 
analyzed (Table 1).
On a note, we found that negative selection strategies were not entirely effective for human peripheral nerve 
cultures due to the lack of a membrane antigen expressed universally in the contaminating populations. Despite 
that rat SC cultures can be depleted of non-glial cells by magnetic separation of Thy-1 positive  cells9, a similar 
strategy was not reliable for human SCs (not shown). Thy-1 (also known as CD90) is a cell surface-anchored 
glycoprotein expressed in fibroblasts rather than  SCs34. Using fluorescently-tagged CD90 antibodies, we con-
firmed the expression of the Thy-1 protein in the  p75NGFR negative populations (Fig. 3c). However, the finding 
of atypical human cultures containing  p75NGFR negative cells that lacked Thy-1 expression (not shown) discour-
aged our use of Thy-1 labeling for MACS. Fibronectin labeling was also discouraged based on empirical data 
showing the inefficacy of monoclonal anti-fibronectin antibodies to separate  p75NGFR negative cells (not shown) 
possibly due to the high levels of fibronectin expressed by SCs (Fig. 2a) or the loss of fibronectin from the cell’s 
surface after trypsinization. For these reasons, and as shown in the following sections, we pursued a strategy 
based on positive selection (with  p75NGFR) rather than negative selection (with Thy-1 or fibronectin) to purify 
human SCs from mixed cultures. To aid in interpretation,  p75NGFR positive, S100β positive cells were referred 
to as ‘SCs’ whereas  p75NGFR negative, S100β negative cells were referred to as ‘fibroblasts’ in the text and figures.
Optimized MACS protocols allow the fast recovery of highly viable human SCs and fibro‑
blasts. Independent human SC cultures were analyzed for their relative content of  p75NFGR positive and nega-
tive cells prior to being enzymatically dissociated and separated via MACS. For this, we essentially followed the 
Table 1.  MACS of human SC cultures affected by different degrees of fibroblast growth. Cellular material from 
8 different cultures were subjected to purification via  p75NGFR immunolabeling and MACS using two types of 
columns, as indicated. Experimental conditions were identical to those described in Figs. 4. Passage and donor 
information for each culture was the following (from top to bottom): passage-2 (17 years old, male); passage-3 
(17 years old, male); passage-2 (66 year old, male), passage-2 (18 year old, male); passage-1 (60 year old, male); 
passage-3 (10 year old, female); passage-3 (60 year old, male); passage-1 (66 year old, male). Quantification 
of S100β and  p75NGFR was carried out by microscopic analysis of serial images obtained by automated 
fluorescence microscopy. The p-value results from the comparison between samples from total and retained 
cells (T-test). The viability was determined by Trypan blue exclusion assays using cells in suspension collected 
immediately after separation. Non-determined measurements are indicated as n.d. Some variability was 
observed in the percentage of SC enrichment in the retained fraction, as determined primarily by the initial 
proportion of SCs versus fibroblasts. The recovery of cells (i.e. the ratio between the pre- and post-sorting cell 
numbers) was variable using MS columns but consistently high using Large Cell columns, which are designed 
for the separation of cells of a larger diameter.
Fibroblasts/SCs Marker
Positive cells (%)
p value Recovery (%) Column typeTotal Eluted Retained
High
p75NGFR 20.2 ± 3.9 0.0 ± 0.0 72.1 ± 3.2  < 0.001
76 MS
S100β 15.5 ± 2.3 0.0 ± 0.0 76.2 ± 4.0  < 0.001
p75NGFR 27.0 ± 4.6 0.0 ± 0.0 73.7 ± 4.9  < 0.001
75 MS
S100β 18.1 ± 4.2 0.0 ± 0.0 74.2 ± 5.2  < 0.001
p75NGFR 70.8 ± 6.7 0.9 ± 0.4 97.6 ± 1.2  < 0.001
51 MS
S100β 72.6 ± 6.0 0.9 ± 0.4 97.8 ± 1.3  < 0.001
Moderate
p75NGFR 75.1 ± 5.9 1.2 ± 0.7 98.1 ± 0.5  < 0.001
n.d MS
S100β 75.3 ± 7.0 1.2 ± 0.7 98.0 ± 0.7  < 0.001
p75NGFR 82.6 ± 2.3 23.6 ± 2.5 99.5 ± 0.2  < 0.001
100 Large cell
S100β 78.1 ± 4.0 23.5 ± 4.1 99.6 ± 0.2  < 0.001
p75NGFR 88.1 ± 3.6 11.5 ± 4.4 98.7 ± 0.5  < 0.001
54 MS
S100β 87.5 ± 2.1 11.2 ± 4.1 98.7 ± 0.5  < 0.001
Low
p75NGFR 88.9 ± 3.3 3.3 ± 1.7 95.6 ± 0.6  < 0.01
n.d MS
S100β 87.8 ± 2.6 3.3 ± 1.7 95.5 ± 0.5  < 0.01
p75NGFR 93.1 ± 3.1 33.9 ± 5.0 98.8 ± 0.9  < 0.05
91 Large cell
S100β 90.9 ± 1.9 33.3 ± 4.0 99.9 ± 0.2  < 0.001
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step-by-step protocol described in our recent  paper11 but introduced proper adaptations as per the content of 
fibroblasts to obtain the highest possible yields and purity in the eluted and retained fractions.
Cell batches containing up to  107 magnetically labelled cells were used for MACS. Samples representative of 
the total (unpurified), retained (enriched in SCs), and eluted fractions (enriched in fibroblasts) were collected 
and analyzed by immunofluorescence microscopy and flow cytometry in order to determine the efficiency of 
separation. Cell counts and viability assays were performed concurrently to estimate the recovery of cells in 
each fraction. Human SC cultures containing fibroblasts at different ratios were selected for optimization and 
troubleshooting the MACS protocol. Moreover, two types of columns (i.e., MS and Large-cell columns) were 
tested upon the realization that further adjustments were needed in consideration of the larger size of human 
SCs and fibroblasts with respect to those of the rat (not shown). The outcome of representative experiments are 
depicted in Fig. 4 and Table 1. We found that a single round of purification was sufficient to achieve high purity 
in cultures containing a majority of SCs irrespective of the type of column used (Table 1). The eluted fractions 
were nearly devoid of SCs with the exception of separations carried out with Large-cell columns, most likely 
due to the larger pore size of the matrix and higher elution speeds. Though some variability was observed in 
independent experiments, Large-cell columns were more reliable to maximize SC purity in the retained fractions. 
Conversely, MS columns were more reliable to minimize SC partitioning into the eluted fraction (Table 1). The 
purified SCs (retained) and fibroblasts (eluted) were highly viable (Table 1 and Fig. 4d), adhered to the laminin 
substrate (Fig. 4a–b) and readily responded to mitogenic stimulation by undergoing proliferation, as inferred by 
their capacity to incorporate EdU (Fig. 4c–d). As shown in Fig. 4c, this method was also appropriate to purify 
senescent SC populations.
Cultures that contained an excess of fibroblasts over SCs required additional rounds of purification to 
attain > 95% SC purity (Table 1). Sequential passing of the retained fraction through an additional column (i.e., 
without introducing an additional labeling step) improved SC purity with the caveat of reduced yield possibly 
due to cell loss during the procedure (not shown). It is well known that SCs undergo apoptosis when deprived 
of trophic support or maintained detached for extended periods of time. That is why we implemented changes 
to minimize the labeling and sorting times and prevent cell death during the procedure. Achieving high purity 
was possible by performing two sequential rounds of MACS with the introduction of an intermediate step of 
cell culture (one to two days) to provide prompt adhesion to the retained fraction before attempting a second 
round of MACS (not shown). The incorporation of 10–20% FBS to the MACS buffer was efficacious to improve 
cell  survival11.
In sum, MACS technology provided a unique tool to separate human SCs and fibroblasts in minimal time 
without compromising the biological activity of the cells for continued culture, direct use in experimentation 
and storage by cryopreservation, as demonstrated for rat  cells9.
Transcriptomics profiling reveals the identity and purity of human SCs and fibroblasts. To 
achieve the highest possible resolution in gene expression profiling, the eluted and retained cells were processed 
for RNA isolation and sequenced via RNA-seq. A stringent statistical data analysis indicated that 12,772 tran-
scripts that matched known sequence reads in the Homo sapiens reference genome were significantly expressed 
in SCs and fibroblasts combined. Differentially expressed genes between SCs and fibroblasts encompassed 
44.88% of the transcriptome. They consisted of 5,228 coding and 504 non-coding transcripts including long 
intergenic non-coding RNAs, as highlighted jointly by the algorithms of two different software packages. The 
volcano plot provides a graphical illustration of the genes expressed exclusively in SCs (445 genes, red dots), 
exclusively in fibroblasts (441 genes, blue dots) and prevalently in each of these populations (green dots). The 
transcripts significantly expressed in either SCs or fibroblasts but not considered differential lie within the cen-
tral area of the plot (black dots). The names of some coding genes in each category were cited in the graphic itself 
for reference to quantitative data shown in Fig. 5b–d.
Overall, the RNA-seq data validated our immunological strategy. The coding transcripts for the proteins 
selected for immunostaining, including S100β (S100B),  p75NGFR (NGFR), Sox10, nestin (NES), Thy-1/CD90 
(THY) and SMA (ACTA2) showed the expected cell type specificity. The mRNA for GFAP, SHH and MAG were 
detected at low levels (< 4 RCPMs) but specifically in SCs. Vimentin (VIM) and CD44 mRNAs were expressed 
at equal levels in both fractions (Fig. 5c), also as predicted by data on the immunodetection of the respective 
proteins.
As expected, the retained fraction displayed genes relevant to the neural crest, the SC phenotype, the control 
of SC proliferation by neuregulin-ErbB signaling, and the myelin program. Albeit some exceptions, myelin-asso-
ciated proteins (including the transcriptional enhancer of myelination EGR2 or Krox20) and enzymes involved 
in myelin lipid biosynthesis were found exclusively in the SC-containing fraction (Fig. 5a,b). It was unexpected 
to find that the transcripts for the myelin protein periaxin (PRX), the genes associated with neurofibromatosis 
(NF1, NF2 and ETV5), and the transcriptional regulator YY1 were equally represented in SCs and fibroblasts 
(Fig. 5a,c), and that Oct7/Brn2 (POU3F2) rather than Oct6 (POU3F1) was the prevalent POU3 isoform in 
human SCs (Fig. 5b). Other coding genes with high and specific representation in the SC fraction included: (1) 
membrane receptors of the integrin family (ITGB8 and ITGA6); and (2) cell surface molecules mediating SC/
SC and SC/neuron interactions, including cadherin-like proteins (CDH19 and PCDH1), nectin-like proteins 
(CADM4 and CADM1) and members of the cell adhesion molecule (CAM) family (L1CAM, NRCAM1, and 
NCAM1/2). In Fig. 5c, the expression of S100A6 and several tubulin isoforms (TUB) are shown as reference 
for their high and equal distribution between the groups. The distribution of all expressed S100 transcripts is 
provided in Supplementary Table 1 to illustrate the many S100 variants expressed in SCs and fibroblasts. In 
Fig. 5d, the most highly expressed cadherin (CDH) isoforms in fibroblasts were selected as examples of genes 
expressed only in these cells. Although fibronectin (FN1) mRNA was one of the most highly expressed genes in 
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fibroblasts (> 50,000 RCPM), it was also expressed at high levels in SCs (> 7,900 RCPM), (Fig. 5d). Consistent with 
the well-established contribution of SCs to ECM formation and  maintenance35, we found that SCs expressed a 
wide range of isoforms for collagen (COL), laminin (LAM) and ECM remodeling enzymes within the MMP and 
ADAMs families (not shown). As a reference, the 25 most differentially expressed transcripts with preferential 
localization in the eluted fraction are provided in Supplementary Table 2.
To summarize, the partitioning of typical mRNA species in each population confirmed the identity of the 
human SCs and the high purity of the preparations obtained via MACS.
Gene clustering analysis of transcriptomics data highlights the origin and immaturity of SCs 
and fibroblasts and the heterogeneity of the fibroblast populations. The list of genes flagged to 





























































































































































































































Figure 4.  Purification of human SC cultures via MACS. Results from representative experiments using 
unpurified human SC populations containing high (a) and low (b–c) fibroblast contamination are shown. Cells 
were labeled in suspension with  p75NGFR antibodies and separated using MS-columns (Methods). Samples from 
the pre-sorting (total) and post-sorting cells were plated in SC growth medium (retained cells) and FBS-only 
medium (eluted cells) for analysis by immunofluorescence microscopy and flow cytometry. The retained and 
eluted cells were highly viable (c), rapidly adhered to the substrate acquiring the expected pattern of growth (a–
c) and underwent proliferation, as denoted by EdU labeling (red nuclei, c). Representative images of a senescent 
human SC culture (passage-4) subjected to MACS is shown in panel c (bottom images, SA-βGAL activity) to 
confirm the absence of senescent cells in the eluted fraction. Observe the negligible representation of S100β and 
 p75NGFR positive cells in the populations of eluted cells (a–c) and the high SC enrichment obtained in one round 
of purification (a). A quantification of the proportion of proliferating (EdU positive) cells discriminated on the 
basis of  p75NGFR expression (green) is shown in panel (d) along with an assessment of viability (Trypan blue 
exclusion assays) for cells in suspension prior to (total) and immediately after MACS (n = 8).
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ware platform for gene clustering and pathway analysis of genome-wide, curated  datasets19. This allowed us to 
interrogate the origin and differentiation of SCs and fibroblasts in an unbiased manner in reference to available 
gene-set libraries of assorted cell types and tissues. The output data from the Jensen Tissues platform highlighted 
the neural crest (ectodermal) and mesenchymal or stromal origins (mesodermal) of the retained and eluted 
cells, respectively (Fig. 6a–b). A significant enrichment in genes collectively known for their role in the initiation 
and maintenance of a stem cell, progenitor state was revealed in both groups (Fig. 6a,c). As such, the human 
SCs expressed transcripts found during embryonic nerve (PNS) development in early neural crest progenitors 
(GAP43, FOXD3, TFAP2A, SOX2, SOX10, NGFR, L1CAM, NES, VIM), SC precursors (PLP1, PMP22, CDH19) 
and immature SCs (PAX3, MPZ, S100B), (Figs. 1 and 6a–b)36. Fibroblasts contained genes encoding for stem 
cell-related receptors and transcriptional regulators such as KIT, TWIST1, TWIST2, FOXC2, PRRX1 and SIX2 
(Fig. 6c). The high immaturity of the human SCs was also suggested by their low levels of GFAP (Fig. 5b), the 
high (> 14 fold) JUN/EGR2 ratio, and the activation of RTK-Ras-MAPK signaling (Fig. 7). Relevant mesenchy-
mal stem cell-associated genes found exclusively in fibroblasts are presented in Fig. 6e with reference to their role 
in cell signaling, transcriptional control, and ECM synthesis/remodeling. Of particular interest is TWIST1, a 
basic helix-loop-helix transcription factor that directly activates PRRX1 (also highlighted in our analysis), which 
is known to maintain the mesenchymal stem cell phenotype as well as the pro-angiogenic and anti-immflama-
tory function of these  cells37. TWIST1 and PRRX1 are part of a fibroblast-specific ON/OFF switch for fibroblast 
activation during wound healing and offer prospect for therapeutic  intervention38. 
Interestingly, the eluted cells contained several transcripts proper of myofibroblasts such as those encoding for 
ACTA1/SMA , DES/desmin, and the myosin light chain-11 (MYH11), (Fig. 6c–d and Supplementary Table 3), 
consistent with image data showing the existence of non-glial cells displaying a nestin negative, SMA positive 
phenotype (Fig. 3a). We found no detectable levels of endothelial- and macrophage-associated genes. However, 
we cannot exclude the presence of perineurial cells, or cells derived therefrom, despite our efforts to remove as 
much of the perineurium as possible during the initial dissection of the nerve fascicles and the absence of the 
typical perineurial gene CLDN1/Claudin-1 (Supplementary Table 3). In fact, the selective partitioning of the 
newly discovered perineurial marker Jedi-1 [36] in the eluted fraction raises the possibility that perineurial cells 
contribute to the heterogeneity of the  p75NGFR negative populations.
Collectively, our results support the feasibility of using high-resolution genomic methods to unambiguously 
determine the lineage specificity and the state of maturation of both SCs and fibroblasts.
Functional analysis of RNAseq data evidences a complex network of interactions between SCs 
and fibroblasts and their complementary, non‑overlapping roles in nerve regeneration. We 
next used enrichR to match our transcriptomics data to functional gene clusters comprising known signal trans-
duction cascades and regulatory elements. The output data from two platforms, namely GO Biological Processes 
and Reactome, was consistent with the existence of a complex network of putative inter-regulatory relationships 
Figure 5.  RNA-seq analysis of MACS-purified human SCs and fibroblasts. (a) Volcano plot denoting the 
partitioning of RNA species in SCs and fibroblasts. Genes expressed only in fibroblasts were coded in blue 
and the ones expressed only in SCs were coded in red. Genes exhibiting > 10–50-fold change in one cell type 
respect to the other were labeled as ‘predominantly’ expressed in SCs (228 genes, green, left side) or fibroblasts 
(228 genes, green, right side). Non-differential genes were coded in black (central area). For a reference, genes 
expressed exclusively in any given cell type included those that exhibited > 2.5 RCPMs in one cell type but no 
more than 1 RCPM in the other, with at least tenfold change difference in RCPM levels (see Methods). (b) 
Selected protein coding genes known to be associated to the SC phenotype and the myelination program. 
(c) Protein coding genes with high representation in both SCs and fibroblasts. (d) Protein coding genes 
in fibroblasts with low or negligible representation in SCs. In all bar graphs, the bar heights represent the 
average RCPM value for each identified gene and the error bars represent SD. All genes were called significant 
(FDR < 0.05) by DESeq2 and edgeR with the exceptions of those displayed in panel (c). The partitioning of 
key SC lineage-specific transcripts in the retained fraction (b) attests both to the efficiency of MACS and the 
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Figure 6.  Tissue enrichment analysis of genes expressed in SCs and fibroblasts. The data reflects the output 
analysis obtained from enrichR using Jensen tissues. The bar graph in (a) was adapted directly from the enrichR 
output data containing the enriched terms (i.e. known cell types most highly represented in the input dataset) 
arranged in decreasing order of significance according to the combined enrichment score. (b) GSEA enrichment 
plots highlight the enrichment of SC- and mesenchyme-related genes in the retained and eluted fractions, 
respectively. The GSEA profiles compared the genes in our data set with previously published data on genes 
expressed in SCs and mesenchymal cells, respectively. In these and all subsequent GSEA plots, the green lines 
(upper area) indicate the enrichment profile, the vertical black lines (mid area) represent the presence of hits (i.e. 
a SC- or mesenchymal cell-specific gene in our dataset), and the lower grey areas, represent the metric scores. 
(c) Venn diagram displaying the matching genes for selected terms (mesenchyme, mesenchymal stem cells, and 
myofibroblasts) in eluted cells to illustrate the gene species accountable for each assignation and their overlap. 
(d) GSEA plot for myofibroblast genes in retained and eluted cells. (e) Most highly expressed genes defining 
the mesenchymal phenotype of fibroblasts organized according to their putative role in transcription, ECM 
synthesis/remodeling and signaling from membrane receptors.
Figure 7.  Signal transduction enrichment analysis in human SCs and fibroblasts. The data reflects the output 
analysis obtained from enrichR using the databases from GO biological processes and Reactome according 
to the enrichment score (x axis). The bar graphs were adapted directly from the enrichR output display of the 
indicated enriched terms which comprise the modules of signal transduction that were most highly represented 
in the input datasets for those genes expressed only in fibroblasts and SCs. As expected, pathway enrichment 
highlighted genes and networks responsible for collagen synthesis, ECM remodeling (assembly/disassembly) 
and basal lamina organization in fibroblasts. In SCs, the pathways with the highest scores were those involved 
in PNS development, maintenance and regeneration as well as cell–cell signaling mediating homophilic and 
heterophilic interactions with nerve cells. The Reactome database unraveled enrichment in MAPK signaling 
components in proliferative human SCs. This finding was expected because of the presence of neuregulin in the 
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among SCs, fibroblasts, neurons and the vasculature. This was in addition to the respective well-recognized roles 
of SCs and fibroblasts in the development and regeneration of the PNS and the formation and remodeling of a 
collagen-rich ECM (Fig. 7), respectively. SCs and fibroblasts were well-equipped with a cell type-specific, mostly 
non-redundant battery of soluble growth factors with potential to act in an autocrine and paracrine fashion in 
SCs and fibroblasts, as suggested by the cell type-related distribution of the membrane receptors for many of 
these ligands (Fig. 8a–b).
The fibroblasts expressed various factors known to control SC behavior. One example was the fibroblast-
specific expression of the gene encoding for neuregulin-1 (NRG1), which has potential to bind to ErbB2 and 
ErbB3 receptors in SCs and enhance their proliferation, survival and migration via RTK-Ras-MAPK  signaling15,16. 
Another example was the expression of GAS6, a ligand for the TAM receptor tyrosine kinase signaling sys-
tem, and a known mitogenic factor for human  SCs39. The expression of the ligand-receptor complexes HGF 
(hepatocyte growth factor)-MET and KITL (KIT ligand)-KIT in fibroblasts suggests the existence of fibroblast-
specific regulatory loops promoting trophic or metabolic support in an autocrine fashion. In addition to this, the 
fibroblasts expressed various isoforms within the EGF, PDGF, TGF/BMP, FGF, and IGF families (Fig. 8a) with 
potential to activate receptors expressed in SCs, fibroblasts (Fig. 8b) and other cell types.
The expression of EGF and PDGF isoforms in SCs suggests their capacity to regulate signaling in fibroblasts 
expressing receptors not found in SCs, such as EGFR and PDGFRA (Figs. 6e and 8b). Hypothetical regulatory 
Figure 8.  Ligand-receptor profiling in SCs and fibroblasts. (a–b) Distribution of transcripts encoding for 
soluble polypeptide growth factors and their cognate plasma membrane receptors. The figure displays selected 
candidate mediators of SC-fibroblast communication and nerve regeneration as initially highlighted by the 
output of GO biological processes and Reactome. The most relevant variants/isoforms (> 5 RCPM in SCs or 
fibroblasts) from each gene family are listed. (c–f) Distribution of transcripts involved in axon guidance and 
growth. GSEA enrichment plot as per Homo sapiens Reactome ID 44245 (c) showing non-overlapping still 
nearly equal enrichment of axon guidance genes in SCs and fibroblasts. Whereas adhesion molecules (CHL1, 
NCAM1, NRCAM, L1CAM), ECM molecules (COL9A3, COL9A2), and components of plexin signaling 
(PLXNB3, SEMA6A, SEMA4D) were highlighted in SCs (d), integrin receptors (ITGA10), and components 
of the ephrin (EPHB6, EPHA7, EPHB2) and netrin signaling pathways (NTN4, UNC5C, ABLIM1) were 
highlighted in fibroblasts (e–f). Ligand-receptor pairing was possible for all of the identified classes of ligands 
(i.e., secreted and membrane-bound ligands) with the exception of VEGF family members (a) whose receptors 
are expected to be present in vascular cells.
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networks with neuronal systems and the vasculature can be inferred by the expression of assorted secretable 
neurotrophic factors and VEGF isoforms, respectively, in SCs and fibroblasts (Fig. 8a). Whereas SCs prevalently 
expressed the transcripts for GDNF and NGF, fibroblasts expressed the ones for BDNF and NTF3 (Fig. 8a). 
These ligands have potential to act both in neurons and SCs, as the latter cells expressed high levels of various 
neurotrophin receptors (Fig. 8b). GFRA members, the receptors for GDNF, were highly and specifically repre-
sented in SCs with the following SC/fibroblast partitioning (in RCPM), GFRA1 (1,510 vs 23.9), GFRA2 (619.8 
vs 0.95), and GFRA3 (277 vs 1.6).
Surprisingly, axon guidance molecules were enriched in both SCs and fibroblasts; albeit predicted to operate 
under an independent mechanistic control in each type of cell (Figs. 7 and 8c). Whereas the axon supportive 
function was linked to NCAM (Fig. 5b) and semaphorin (SEMA)-plexin (PLXN) signaling in SCs (Figs. 7, 8d), 
it was linked to ephrin (EFN)-ephrin receptor (EPH) and netrin (NTN) signaling in fibroblasts (Figs. 7,8e–f). 
Curiously, netrin ligands were mostly expressed in SCs and netrin receptors (UNC5 rather than DCC) in fibro-
blasts (Fig. 8f). The distribution of SEMA-PLXN and EFN-EPH isoforms suggests the possibility of auto- and 
inter-regulatory signaling involving SCs and fibroblasts.
This data is consistent with the existence of reciprocal regulatory networks between SCs and fibroblasts pos-
sibly at play during nerve regeneration (Fig. 9). It seems plausible that SCs and fibroblasts modulate their own 
function and that of various other cellular components in peripheral nerves via multiple mechanisms of cell–cell 
communication and ECM  remodeling40.
Discussion
In this study, we combined the use of immunofluorescence microscopy analysis, flow cytometry and RNA-seq 
to unequivocally characterize the prevailing phenotypes developing in primary adult human nerve cultures 
(Fig. 1). We present useful tools, including effective antibody combinations to detect human antigens, and 
MACS protocols developed in our lab that enable the highest possible efficiency of separation of the glial cell 
component while preserving the viability and purity of the non-glial fraction. Our elaborated transcriptomic 
analysis underscored the independent origin of SCs and fibroblasts, and the complexity of the SC-fibroblast 
interrelationship at the molecular level (Fig. 9). The novel methods and concepts presented here are relevant to 
the study of whole nerve  tissues41, SC-like cells generated from stem cell  sources42 and neural crest-derived cells 
including but not restricted to SCs.
Fibroblast contamination and the need for human‑specific methods for analysis and purifica‑
tion. The expansion of the usually small pool of human SCs recovered from a nerve biopsy has been pos-
sible since the introduction of the mitogenic combination consisting of neuregulin and  forskolin5,23. However, 
these chemical factors do not allow a continuous increase in human SC numbers (as shown for rat SCs), nor 
do they prevent their purity to be jeopardized by fibroblast overgrowth. Differential adhesion to plastic is a fast 
and inexpensive method that has been adopted to manufacture clinical grade human SCs because no addi-
tional chemicals are introduced to the culture  workflow43. However, this simple method has value for human 
SC enrichment rather than fibroblast removal. Whereas complement-mediated cell lysis with Thy-1 antibodies 
can deplete postnatal and adult rat SCs of contaminating  fibroblasts34,44 we found this strategy to be ineffec-
tive for human SC cultures due to the heterogeneous nature of the contaminating cell types. Instead, MACS 
could readily and effectively deprive human SCs of contaminant cells, and concomitantly retrieve the unlabeled 
fraction, in any population containing  p75NGFR positive cells. This is an important advantage over purification 
protocols based on selective or non-selective cell killing or adhesion. In addition, MACS is a clinically relevant 
tool for therapeutic monitoring, diagnosis and  therapy45. Magnetic sorting technologies that are similar to the 
research-grade ones used herein have been approved for clinical use under good manufacturing  practices46. In 
addition to the strong cell type selectivity, MACS can isolate rare cells within a  population47. MACS has allowed 
the separation of circulating tumor cells for metastatic cancer  prognosis48 and of endothelial cells for the assess-
ment of cardiovascular  injury49, thereby making it ideal to possibly isolate SC-like cells from tumors and other 
unconventional locations.
The early detection and elimination of non-glial cells is essential for any intended use of the human SC cul-
tures but it is particularly relevant in SC auto-transplantation  therapy10,50. Although they were first described as 
cells of mesodermal origin, fibroblasts are known to exist in different populations. Some fibroblasts derive from 
the neural crest and have an ectodermal  origin51. The diversity and heterogeneity of fibroblasts thwarts the find-
ing of a general fibroblast-specific marker. We found that human nerve-derived fibroblasts are an heterogeneous, 
non-senescent population different from rodent fibroblasts which are known to acquire senescence in vitro52. 
Some fundamental differences in the expression of certain genes became apparent between human peripheral 
nerve fibroblasts that are PAX3 negative, ETV5 positive (our study) and skin-derived fibroblasts from the human 
dermis that are PAX3 positive, ETV5 negative as described by Stratton et al.26. Most strikingly, peripheral nerve 
fibroblasts displayed a strong neural signature as judged by their high levels of expression of genes responsible 
for the development and regeneration of neural tissues. In fact, a general understanding is that the phenotype of 
fibroblasts is varied and may be dependent on the species in question and the tissue of  origin53.
Even though we have defined the eluted cells collectively as ‘fibroblasts’, we understand that they are an 
undefined and variable group of cells whose origin is still uncertain. We assume that the majority of the  p75NGFR 
negative cells derive from endoneurial fibroblasts but the expression of SMA suggests the presence of  pericytes29. 
It is possible that the SMA positive cells found in our human nerve cultures are analogous to the mouse nerve 
pericytes described by Stierli et al.54 as  p75NGFR negative, NG2 positive, PDGFRβ positive, ACTA/SMA positive 
 cells54. Yet, the eluted cells do not seem to contain endoneurial fibroblasts analogous to the ones reported in the 
same study (defined as  p75NGFR positive, S100β negative, NG2 positive, PDGFRβ positive, SMA negative cells) 
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mainly because of the lack of S100β negative,  p75NGFR positive cells our typical preparations. Nevertheless, it 
is possible that our cultures contain perineurial cells that have lost typical cell adhesion markers such as Clau-
din-1. Whether different nerves render cultures with different characteristics or levels of purity is unknown, as 
many sources of variability can affect the quality and quantity of the human SC  cultures13. The heterogeneity of 
the populations may reflect the influence of extracellular factors in gene expression profiles or an unintended 
selection of the most aggressive phenotypes. Yet, we assume that basic characteristics, such as the expression of 
lineage-specific genes, are rather constant and not artefactual from the culture  conditions13,28. To this end, more 
studies are needed to trace the SCs and non-glial cells from the nerve to the culture. A more elaborated analysis of 
the constitution of the human SC cultures via single cell RNA-seq analysis and/or further purification of existing 
phenotypes could be particularly enlightening regarding cell type identification.
The power of transcriptomics to unravel novel features of human SCs and fibroblasts. The 
availability of the whole transcriptome has enabled us to rigorously compare human SCs and fibroblasts as well 
as to establish unbiased links to phenotypic and functional states on the basis of existent high-resolution data-
sets. Our characterization of human SCs was, for the most part, consistent with published data on human SC 
cultures from  nerve14,27 and  skin26. Yet, our analysis revealed a myriad of differentially expressed transcripts with 
prevalent representation in SCs and fibroblasts that offer potential to be considered as cell type-specific identi-
fiers or be further investigated for their role in human nerve physiology or pathology. Curiously, the fibroblasts 
displayed a mesenchymal stem cell phenotype. This is consistent with previous findings showing that fibroblasts 
within the connective tissue sheaths of avian peripheral nerves derive from the mesenchyme rather than the 
neural  crest55, that Thy-1 positive cells from rat nerves give rise to perineurium in vitro56, and that multipotent 
mesenchymal precursor cells from adult nerves contribute to skin repair and digit tip  regeneration57.
One shared property between SCs and fibroblasts was their marked profile of undifferentiated, progenitor-
like cells with concomitant expression of assorted, yet mostly non-overlapping, neural-related genes. The rela-
tive immaturity of cultured human SCs has been previously recognized by functional studies of neuron-glia 
 interactions14 and their immunological profile consistent with the repair SC  phenotype27. New studies in mice 
Figure 9.  Auto and heterotypic interactions between SCs and fibroblasts in nerve regeneration. The RNA-seq 
profiling unmasked key hypothetical connections among human SCs and fibroblasts operating via multiple 
signaling mechanisms. Paracrine signaling from SCs and fibroblasts targeting neurons and/or other cellular 
components within the nerves, such as the vasculature and immune cells (not shown), can also be anticipated 
based on RNAseq profiling. Examples of potential molecular players mediating autocrine (red arrows) and 
paracrine (blue and green arrows) interactions are described in Figs. 7 and 8, and the text.
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have shown that the wound microenvironment can drive SCs to acquire an invasive, mesenchymal-like state 
in vivo58 but it seems possible that some traits acquired in response to axon-deprivation (or injury induction) 
are also maintained or recapitulated in vitro. It is hard to ascertain the origin of the human SCs by examination 
of their molecular characteristics in vitro. This was clearly demonstrated by Stratton et al. who reported that 
skin-derived and nerve-derived cultured human SCs are transcriptionally  undistinguishable26. We have found 
that extended passaging affects the expression of certain genes involved in cell cycle control but we have not seen 
changes in the levels of S100β,  p75NGFR or any of the markers used here for SC identification. The SC transcrip-
tome is remarkably stable with  subculture59 but whether this is the case for fibroblasts is unknown.
The immaturity of fibroblasts was by far intriguing but was consistent with their high proliferative capacity 
and lack of replicative senescence. Our functional analysis of the transcriptome suggests that the fibroblasts 
provide crucial mitogenic and survival factors to human SCs, including neuregulin and GAS6. A role for SCs 
in modulating aspects of fibroblast physiology via membrane-membrane signaling and soluble ligands was 
also revealed. The cell type-specific distribution of ligands and receptors involved in cell–cell interactions via 
homophilic and heterophilic plasma membrane adhesion molecules, as well as the profile of secreted factors 
(including neurotrophic factors) was consistent with current knowledge regarding the interplay between SCs 
and fibroblasts in controlling nerve regeneration. Ephrin, netrin and plexin were three major players identified 
to possibly mediate SC-fibroblast interactions or interactions with neuronal cells supporting axon growth and 
guidance. Our findings are in agreement with previous studies showing that EphrinB/EphB2 signaling between 
fibroblasts and SCs directs the coordinated migration of SCs to guide regenerating axons across the  bridge8 and 
that Netrin-1 secreted by SCs interacts with DCC receptors on axons to direct their  growth60,61. Recent research 
has shown that Ephrin signaling plays a role during SC invasion of CNS  lesions62. How the plexin pathway 
regulates PNS regeneration is poorly understood but the high representation and diversity of SEMA and PLXN 
isoforms in both SCs and fibroblasts suggests the importance of this pathway in mediating bidirectional SC-to-
fibroblast communication.
Concluding remarks. The unique potential of SCs for remyelination along with their provision of an extra-
cellular environment supportive of neural regeneration have converted these glial cells into excellent candi-
dates for transplantation in the PNS and CNS when used as purified cells or tissue  grafts41,50. The traditional 
view that fibroblasts contribute scar tissue and negatively affect the outcome of SC transplantation is changing 
upon new evidence indicating that they assist in tissue regeneration. Fibroblasts promote neurite outgrowth and 
secrete growth factors and ECM proteins able to stimulate SC  migration40,63,64. The expression of neurotrophic 
factors and adhesion molecules supportive of axon growth and pathfinding in fibroblasts further sustain this 
emerging view. Indeed, it seems that reciprocal signaling between SCs and fibroblasts contribute to cell prolif-
eration, migration, ECM remodeling, and communication with other nerve-resident cell types. Exploiting the 
pro-regenerative properties of PNS-derived fibroblasts, alone or in combination with SCs, may be considered to 
optimize therapeutic approaches or evaluate the outcome of preclinical and clinical studies of cell transplants.
Altogether, our studies showed that MACS technology can readily separate human SCs and fibroblasts with 
retention of biological activity in both populations. Not only are these methods versatile but also lend them-
selves suitable to the manufacture of clinical grade human SCs for diagnosis or grafting. The transcriptome is 
a valuable reference tool for cell phenotyping and comparisons of RNA expression profiles in single cells and 
whole tissues deriving from humans. This tool is ideal for elaborating new mechanistic hypotheses and search-
ing for candidate molecules with potential use in selective cell targeting, in vitro modeling of disease states, and 
regenerative therapies.
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